Is GSK plc overvalued?

GSK plc (GSK) looks undervalued — trading about 29% below its fair value.

Undervalued

Price

$51.15

Fair value

$65.75

Current P/E

11.7

Normal P/E

15.1

Market cap

$102.48B

Dividend yield

3.5%

Return on equity

24.4%

Sector

Healthcare

Fair value compares GSK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks